Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (5): 897-901. doi: 10.19723/j.issn.1671-167X.2020.05.017

Previous Articles     Next Articles

Multicenter performance of the different classification criteria for rheumatoid arthritis

Cai-nan LUO1,Zheng-fang LI1,Li-jun WU1,(),Hai-juan CHEN2,Chun-mei YANG2,Wen-hui XU3,Xiao-ling LIU4,Wei TANG2,Ping QIAO3,Baihetiya Rena4   

  1. 1. Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Ugyur Autonomous Region, Urumuqi 830001, China
    2. Department of Rheumatology and Immunology, People’s Hospital of Changji, Changji 831100, Xinjiang, China
    3. Department of Rheumatology and Immunology, People’s Hospital of Aletai Region, Aletai 836500, Xinjiang, China
    4. Department of Rheumatology and Immunology, First People’s Hospital of Kashgar Region, Kashgar 844000, Xinjiang, China
  • Received:2018-11-10 Online:2020-10-18 Published:2020-10-15
  • Contact: Li-jun WU E-mail:wwlj330@126.com

Abstract:

Objective: To evaluate the classification criteria of early rheumatoid arthritis (ERA) and compare the sensitivity and specificity with the criteria of 1987 American College of Rheumatology (ACR) criteria and 2010 ACR/European League Against Rheumatism (EULAR). Methods: Patients from 4 hospitals, aged more than 16 years, with arthritis, whose disease duration was ≤1 year, and with ≥1 joint pain and swelling were enrolled in the study. The indicators including clinical manifestations, laboratory tests and imaging examinations were observed. The ERA patients were dignosed by two experienced rheumatologists based on the clinical features, drug therapy information and radiography features. Results: (1) A total of 325 patients with arthritis were enrolled, including 98 males (30.15%) and 227 females (69.85%), The average age was (47.53±14.44) years, and the median disease duration was 5 (2, 8) months. Finally, 236 patients were dignosed with ERA, and 89 patients were dignosed with other diseases (Non-ERA, including osteoarthritis, reactive arthritis, undifferentiated arthritis, spondyloarthritis, etc). (2) The sensitivity of ERA criteria was 87.29%, and the specificity was 84.37%. The sensitivity was higher than that of 1987 ACR criteria (χ 2=43.641, P<0.001), and had no significant difference compared with 2010 ACR/EULAR criteria (χ2=0.446, P=0.593). But the specificity of ERA criteria was lower than that of 1987 ACR criteria (χ2=4.891, P=0.027), which was not statistically significant compared with 2010 ACR/EULAR criteria (χ2=0.044, P=1.000). (3) In the patients with arthritis whose disease duration was ≤3 months and ≤6 months, the sensitivity of ERA criteria was 81.71% and 86.79%, respectively, both were higher than the 1987 ACR criteria (χ2=7.131, P=0.008; χ2=22.015, P<0.001) and had no statistically difference compared with the 2010 ACR/EULAR criteria (χ2=0.220,P=0.755; χ2=0.473,P=0.491). The differences of the three criteria in specificity were not statistically significant. (4) The three different classification criteria were consistent with the clinical diagnosis, among which the ERA criteria and 2010 ACR/EULAR criteria were slightly higher (Kappa>0.6). The results of the consistency comparison between the three criteria showed that the ERA criteria and 2010 ACR/EULAR criteria had a better consistency (Kappa=0.836). Conclusion: The sensitivity of ERA classification criteria in the diagnosis of ERA was higher than that of 1987 ACR criteria, and was equivalent to that of 2010 ACR/EULAR criteria. There is no significant difference in specificity between these three criteria. The ERA criteria can also identify patients with RA at a very early stage in arthritis with disease duration ≤3 months.

Key words: Arthritis, Rheumatoid arthritis, Early diagnosis

CLC Number: 

  • R593.22

Table 1

Clinical charasteristics of ERA and non-ERA patients"

Items ERA(n=236) Non-ERA(n=89) P
Male/female, n 60/176 38/51 0.002
Age/years, x-±s 49.59±13.85 44.89±15.70 0.001
Disease duration/months, median (IQR) 5(2.25, 8.00) 3(1.00,10.00) 0.068
Swollen joint count, median (IQR) 5(2, 10) 2(1, 4) <0.001
Tender joint count, median (IQR) 11(6, 20) 4(2, 10) <0.001
Morning stiffness(>30 min), n(%) 151(63.98) 14(15.73) <0.001
RF positive, n(%) 162(68.64) 8(8.99) <0.001
Anti-CCP positive, n(%) 183(77.54) 6(6.74) <0.001
ESR/(mm/h), median (IQR) 41.50(24.00, 59.75) 27.00(14.00, 54.00) 0.008
CRP/(mg/L), median (IQR) 11.60(4.60, 36.38) 10.11(2.00, 46.48) 0.287

Table 2

Clinical charasteristics of patients with arthritis whose disease duration ≤3 months and ≤6 months"

Items Disease duration≤3 months(n=129) Disease duration≤6 months(n=220) P
Male/female, n 43/86 74/146 0.954
Age/years, x-±s 47.09±15.89 49.80±14.16 0.345
Swollen joint count, median (IQR) 4(1, 8) 4(1, 9) 0.688
Tender joint count, median (IQR) 7(3, 14) 8(4, 18) 0.063
Morning stiffness(>30 min), n(%) 66(51.16) 115(52.27) 0.841
RF positive, n(%) 56(43.41) 115(52.27) 0.110
anti-CCP positive, n(%) 62(48.06) 125(56.82) 0.113
ESR, mm/h, median (IQR) 39.00(20.75, 58.00) 40.00(22.00, 58.25) 0.758
CRP, mg/L, median (IQR) 13.26(3.04, 44.79) 11.60(4.17, 42.40) 0.839

Table 3

Sensitivity and specificity of 3 classification criterias in patients with arthritis"

Classification criteria Sensitivity/% Specificity/% Positive predictive value/% Negative predictive value/%
ERA 87.29 84.27 93.64 71.43
1987 ACR 60.59 94.38 96.62 47.45
2010 ACR/EULAR 85.17 86.52 94.37 68.75

Table 4

Sensitivity and specificity of 3 classification criterias in arthritis patients with disease duration ≤3 months"

Classification criteria Sensitivity/% Specificity/% Positive predictive value/% Negative predictive value/%
ERA 81.71 91.49 94.37 74.14
1987 ACR 54.88 100.00 100.00 63.51
2010 ACR/EULAR 79.27 93.62 95.59 72.13

Table 5

Sensitivity and specificity of 3 classification criterias in arthritis patients with disease duration ≤6 months"

Classification criteria Sensitivity/% Specificity/% Positive predictive value/% Negative predictive value/%
ERA 86.79 90.12 94.52 77.66
1987 ACR 64.15 97.53 98.08 25.00
2010 ACR/EULAR 83.02 91.36 94.96 73.27

Table 6

Comparision of consistency between clinical diagnosis and 3 classification criterias"

Items Consistency
rate/%
Kappa P
Clinical diagnosis & ERA 86.46 0.678 <0.001
Clinical diagnosis & 1987 ACR 69.85 0.420 <0.001
Clinical diagnosis & 2010
ACR/EULAR
85.54 0.663 <0.001

Table 7

Comparision of consistency among 3 classification criterias"

Items Consistency
rate/%
Kappa P
ERA & 1987 ACR 78.15 0.577 <0.001
ERA & 2010 ACR/EULAR 92.31 0.836 <0.001
2010 ACR/EULAR & 1987 ACR 75.38 0.521 <0.001
[1] 赵金霞, 苏茵, 刘湘源, 等. 早期类风湿关节炎分类标准及其诊断意义的探讨[J]. 中华风湿病学杂志, 2012,16(10):651-656.
[2] Zhao J, Su Y, Li R, et al. Classification criteria of early rheumatoid arthritis and validation of its performance in a multi-centre cohort[J]. Clin Exp Rheumatol, 2014,32(5):667-673.
[3] 李玉翠, 范文强, 陈海英, 等. 2012年早期类风湿关节炎分类标准的国内多中心临床验证[J]. 中华风湿病学杂志, 2017,21(12):807-811.
[4] 叶华, 苏茵, 李茹, 等. 早期类风湿关节炎分类标准的全国多中心临床验证[J]. 中华风湿病学杂志, 2014,18(12):802-805.
[5] Ye H, Su Y, Li R, et al. Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort[J]. Clin Rheumatol, 2016,35(10):2397-2401.
doi: 10.1007/s10067-016-3281-2 pmid: 27129710
[6] Radner H, Neogi T, Smolen JS, et al. Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: A systematic literature review[J]. Ann Rheum Dis, 2014,73(1):114-123.
doi: 10.1136/annrheumdis-2013-203284
[7] van der Linden MP, Knevel R, Huizinga TW, et al. Classification of rheumatoid arthritis: Comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria[J]. Arthritis Rheum, 2011,63(1):37-42.
doi: 10.1002/art.30100 pmid: 20967854
[8] Biliavska I, Stamm TA, Martinez-Avila J, et al. Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort[J]. Ann Rheum Dis, 2013,72(8):1335-1341.
doi: 10.1136/annrheumdis-2012-201909
[1] Zhi-bo SONG,Yan GENG,Xue-rong DENG,Xiao-hui ZHANG,Zhuo-li ZHANG. Benefit of ultrasound in the phenotype recognition of psoriatic arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1061-1066.
[2] Lu ZHANG,Xiao-hong HU,Cheng CHEN,Yue-ming CAI,Qing-wen WANG,Jin-xia ZHAO. Analysis of cervical instability and clinical characteristics in treatment-naive rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1049-1054.
[3] Xue-rong DENG,Xiao-ying SUN,Zhuo-li ZHANG. Agreement between ultrasound-detected inflammation and clinical signs in ankles and feet joints in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1037-1042.
[4] Liang LUO,Wen-gang HUO,Qin ZHANG,Chun LI. Clinical characteristics and risk factors of rheumatoid arthritis with ulcerative keratitis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1032-1036.
[5] Hua ZHONG,Li-ling XU,Ming-xin BAI,Yin SU. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026-1031.
[6] Xue LOU,Li LIAO,Xing-jun LI,Nan WANG,Shuang LIU,Ruo-mei CUI,Jian XU. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025.
[7] Zheng-fang LI,Xue WU,Li-jun WU,Cai-nan LUO,Ya-mei SHI,Yan ZHONG,Xiao-mei CHEN,Xin-yan MENG. Clinical features of patients with Rhupus syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 933-937.
[8] Hao WU,Li-ping PAN,Heng LIU,Hong-bin WANG,Tai-guo NING,Yong-ping CAO. Effect of posterior tibial slope on the short-term outcome in mobile-bearing unicompartmental knee arthroplasty [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 877-882.
[9] Cheng WANG,Ling-yu MENG,Na-yun CHEN,Dai LI,Jian-quan WANG,Ying-fang AO. Management algorithm for septic arthritis after anterior cruciate ligament reconstruction [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 850-856.
[10] WANG Gui-hong,ZUO Ting,LI Ran,ZUO Zheng-cai. Effect of rebamipide on the acute gouty arthritis in rats induced by monosodium urate crystals [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 716-720.
[11] WU Jun-hui,CHEN Hong-bo,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,WANG Meng-ying,WANG Si-yue,WANG Xiao-wen,WANG Jia-ting,YU Huan,HU Yong-hua. Prevalence and risk factors of osteoarthritis in patients with type 2 diabetes in Beijing, China from 2015 to 2017 [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 518-522.
[12] ZHAO Kai,CHANG Zhi-fang,WANG Zhi-hua,PANG Chun-yan,WANG Yong-fu. Therapeutic effect of gene silencing peptidyl arginine deaminase 4 on pulmonary interstitial lesions induced by collagen-induced arthritis mice [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 235-239.
[13] CAO Di,WANG Yan,WANG Liu-qing,SUN Xiao-lin,HUANG Fei,MENG Yang,REN Li-li,ZHANG Xue-wu. Expression of plasma Dickkopf-1 in patients with rheumatoid arthritis and its correlation with peripheral blood T cell subsets [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 255-260.
[14] KE Yan,ZHANG Qiang,MA Yun-qing,LI Ru-jun,TAO Ke,GUI Xian-ge,LI Ke-peng,ZHANG Hong,LIN Jian-hao. Short-term outcomes of total hip arthroplasty in the treatment of Tönnis grade 3 hip osteoarthritis in patients with spondyloepiphyseal dysplasia [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 175-182.
[15] Shi-xiong WEI,Shu-jia LI,Yi LIU. Clinical characteristics and biological treatment of adult patient with juvenile idiopathic arthritis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1014-1022.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .